Appointments to the Boards of Directors 01 | 01

Posted on July 18, 2022

Appointments to the Boards of Directors
of the UbiPharm companies

Le Grand-Quevilly, July 14th, 2022

On June 16, 2022, the Board of Directors of the UbiPharm group appointed Mr. NDOUMOU OBAME Daniel as the new Board Chairman, replacing Mr. DAO Boukary.

New Board Chairman in Mali, Senegal, and Togo

The subsidiaries of UbiPharm Mali, UbiPharm Senegal, and UbiPharm Togo have recently appointed the new Board Chairman of their respective company.

  • Mr. DIARRA Bréhima, Board Chairman of UbiPharm Mali, effective on May 11, 2022
  • Mr. DIEDHIOU Moussa, Board Chairman of UbiPharm Senegal, effective on June 8, 2022
  • Ms. DOVIE-AKUE Kokoe Emilie, Board Chairman of UbiPharm Togo, effective on May 20, 2022
  • Mr. NDOUMOU OBAME Daniel also becomes the new Board Chairman of Gesca, ​​ Group’s auditing subsidiary.

The mandate of the new Chairmen runs for a period of 2 years, in accordance with the rotating mode of presidency in force within the UbiPharm group.

The UbiPharm group warmly thanks for the years of service the outgoing Presidents:

  • Mr. DAO Boukary, Board Chairman of UbiPharm and Gesca;
  • Mr. OUATTARA Béma, Board Chairman of UbiPharm Mali;
  • Ms. BA SOW Fatimata, Board Chairman of UbiPharm Senegal et
  • Ms. D’ALMEIDA Mawussé, Board Chairman of UbiPharm Togo.

About UbiPharm

With a presence in 14 African countries and 4 French overseas departments and territories, UbiPharm continues to promote access to healthcare solutions. With a turnover of 882 million euros in 2020 and 1,750 employees, this supply chain expert integrates five businesses: wholesale distributor, distribution, logistics, promotion and depository.

With an innovative customer-shareholder model and a high-performance and responsible distribution system, UbiPharm is proud to support healthcare players by creating close relationships that benefit everyone.


Health at hand, now. 

For more information: